HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,264,000 | +46.0% | 140,586 | +29.8% | 0.07% | +62.2% |
| Q2 2023 | $11,139,000 | -8.9% | 108,307 | -3.3% | 0.04% | -11.8% |
| Q1 2023 | $12,230,000 | -7.7% | 112,058 | -3.7% | 0.05% | -10.5% |
| Q4 2022 | $13,248,000 | +82.3% | 116,417 | -0.9% | 0.06% | +72.7% |
| Q3 2022 | $7,269,000 | -40.2% | 117,447 | -23.0% | 0.03% | -36.5% |
| Q2 2022 | $12,162,000 | -40.0% | 152,478 | -20.8% | 0.05% | -26.8% |
| Q1 2022 | $20,256,000 | +26.2% | 192,528 | +29.3% | 0.07% | +31.5% |
| Q4 2021 | $16,051,000 | -0.4% | 148,956 | +1.3% | 0.05% | -5.3% |
| Q3 2021 | $16,109,000 | +27.0% | 147,059 | +8.5% | 0.06% | +26.7% |
| Q2 2021 | $12,687,000 | +11.9% | 135,489 | +10.0% | 0.04% | 0.0% |
| Q1 2021 | $11,335,000 | +31.2% | 123,153 | +4.3% | 0.04% | +15.4% |
| Q4 2020 | $8,638,000 | – | 118,091 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |